دورية أكاديمية
Should you thrombolyse all or any stroke patients with baseline National Institutes of Health stroke scale scores < or = 5?
العنوان: | Should you thrombolyse all or any stroke patients with baseline National Institutes of Health stroke scale scores < or = 5? |
---|---|
المؤلفون: | Steffenhagen N; Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alta., Canada. nikolai.steffenhagen@Medizin.Uni-Leipzig.de, Hill MD, Poppe AY, Buchan AM, Coutts SB |
المصدر: | Cerebrovascular diseases (Basel, Switzerland) [Cerebrovasc Dis] 2009; Vol. 28 (2), pp. 201-2. Date of Electronic Publication: 2009 Jun 30. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Karger Country of Publication: Switzerland NLM ID: 9100851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9786 (Electronic) Linking ISSN: 10159770 NLM ISO Abbreviation: Cerebrovasc Dis Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Basel ; New York : Karger, 1990- |
مواضيع طبية MeSH: | National Institutes of Health (U.S.)* , Patient Selection* , Thrombolytic Therapy*/adverse effects, Fibrinolytic Agents/*administration & dosage , Stroke/*drug therapy , Tissue Plasminogen Activator/*administration & dosage, Aged ; Aged, 80 and over ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Intracranial Hemorrhages/etiology ; Male ; Middle Aged ; Odds Ratio ; Registries ; Risk Assessment ; Severity of Illness Index ; Stroke/diagnosis ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome ; United States |
معلومات مُعتمدة: | G0500495 United Kingdom MRC_ Medical Research Council |
المشرفين على المادة: | 0 (Fibrinolytic Agents) EC 3.4.21.68 (Tissue Plasminogen Activator) |
تواريخ الأحداث: | Date Created: 20090703 Date Completed: 20090924 Latest Revision: 20211020 |
رمز التحديث: | 20240829 |
DOI: | 10.1159/000226579 |
PMID: | 19571531 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1421-9786 |
---|---|
DOI: | 10.1159/000226579 |